{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T23:53:55Z","timestamp":1784850835391,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ijrobp.2018.01.105","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T07:35:18Z","timestamp":1517902518000},"page":"316-324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 Trial"],"prefix":"10.1016","volume":"101","author":[{"given":"Youssef H.","family":"Zeidan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce G.","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieveke","family":"Ameye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Paesmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evandro","family":"de Azambuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Gelber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Nordenskj\u00f6ld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Guti\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Lluch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gnant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron","family":"Goldhirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Di Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Crown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Piccart-Gebhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prudence A.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2018.01.105_bib1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJM199710023371401","article-title":"Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b trial","volume":"337","author":"Overgaard","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib2","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(98)09201-0","article-title":"Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial","volume":"353","author":"Overgaard","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib3","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199710023371402","article-title":"Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer","volume":"337","author":"Ragaz","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.radonc.2007.02.001","article-title":"Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials","volume":"82","author":"Overgaard","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib5","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","article-title":"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: Meta-analysis of individual patient data for 8135 women in 22 randomised trials","volume":"383","author":"McGale","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib6","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1200\/JCO.2004.01.042","volume":"22","author":"Taghian","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1200\/JCO.2005.12.044","article-title":"Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer: Cancer and Leukemia Group B 9344","volume":"23","author":"Sartor","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1748-717X-6-28","article-title":"Postmastectomy irradiation in breast in breast cancer patients with T1-2 and 1-3 positive axillary lymph nodes: Is there a role for radiation therapy?","volume":"6","author":"Cosar","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib9","doi-asserted-by":"crossref","first-page":"e0119105","DOI":"10.1371\/journal.pone.0119105","article-title":"Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes","volume":"10","author":"He","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib10","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1245\/s10434-013-3117-0","article-title":"Selection criteria for postmastectomy radiotherapy in T1-T2 tumors with 1 to 3 positive lymph nodes","volume":"20","author":"Moo","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib11","doi-asserted-by":"crossref","first-page":"e577","DOI":"10.1016\/j.ijrobp.2012.01.076","article-title":"Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy","volume":"83","author":"Tendulkar","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jnci\/djm287","article-title":"Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial","volume":"100","author":"Francis","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib13","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/annonc\/mds627","article-title":"Overall survival benefit for sequential doxorubicin-docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer\u20138-year results of the Breast International Group 02-98 phase III trial","volume":"24","author":"Oakman","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib14","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.ejca.2015.03.018","article-title":"Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer","volume":"51","author":"Sonnenblick","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib15","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.2007.14.5565","article-title":"Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: The Danish Breast Cancer Cooperative Group","volume":"26","author":"Kyndi","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib16","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s10549-011-1495-1","article-title":"Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation","volume":"128","author":"Panoff","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib17","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/annonc\/mdv159","article-title":"No clear effect of postoperative radiotherapy on survival of breast cancer patients with one to three positive nodes: A population-based study","volume":"26","author":"Nordenskjold","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib18","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ijrobp.2014.02.013","article-title":"Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment","volume":"89","author":"McBride","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib19","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/annonc\/mdx308","article-title":"De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017","volume":"28","author":"Curigliano","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/annonc\/mdx543","article-title":"Reply to \u201cThe St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: The point of view of an international panel of experts in radiation oncology\u201d by Kirova, et\u00a0al","volume":"29","author":"Dubsky","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.radonc.2017.03.001","article-title":"The effect of post-mastectomy radiation in women with one to three positive nodes enrolled on the control arm of BCIRG-005 at ten year follow-up","volume":"123","author":"Tam","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib22","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1200\/JCO.2016.69.1188","article-title":"Postmastectomy radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology focused guideline update","volume":"34","author":"Recht","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib23","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1200\/JCO.2000.18.15.2817","article-title":"Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: Implications for postoperative irradiation","volume":"18","author":"Katz","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib24","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ijrobp.2009.01.007","article-title":"Chest wall radiotherapy: Middle ground for\u00a0treatment of patients with one to three positive lymph nodes after mastectomy","volume":"75","author":"Macdonald","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib25","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1200\/JCO.1999.17.6.1689","article-title":"Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group","volume":"17","author":"Recht","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clon.2007.10.004","article-title":"Elucidating the role of chest wall irradiation in \u2018intermediate-risk\u2019 breast cancer: The MRC\/EORTC SUPREMO trial","volume":"20","author":"Kunkler","year":"2008","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1415369","article-title":"Internal mammary and medial supraclavicular irradiation in breast cancer","volume":"373","author":"Poortmans","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib28","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1186\/bcr3197","article-title":"Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy","volume":"14","author":"Dominici","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib29","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ijrobp.2015.07.006","article-title":"Biological subtype predicts risk of locoregional recurrence after mastectomy and impact of postmastectomy radiation in a large national database","volume":"93","author":"Tseng","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib30","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1200\/JCO.2016.70.7158","article-title":"Hypofractionated postmastectomy radiation therapy is safe and effective: First results from a prospective phase II trial","volume":"35","author":"Khan","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib31","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.soc.2017.01.010","article-title":"Updates in postmastectomy radiation","volume":"26","author":"Wright","year":"2017","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.ijrobp.2018.01.105_bib32","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): A randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161830230X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161830230X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T16:46:50Z","timestamp":1603817210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030161830230X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S036030161830230X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.01.105","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.01.105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}